참고문헌 (24)

1. 1 Kwei GY , Alvaro RF , Chen Q , Jenkins HJ , Hop CE , Keohane CA , Ly VT , Strauss JR , Wang RW , Wang Z , Pippert TR , Umbenhauer DR . 1999 . Disposition of ivermectin and cyclosporin A in CF‐1 mice deficient in mdr1a P‐glycoprotein . Drug Metab Dispos 27 : 581 – 587 . 

   상세보기

2. 2 Schinkel AH , Smit JJ , van Tellingen O , Beijnen JH , Wagenaar E , van Deemter L , Mol CA , van der Valk MA , Robanus‐Maandag EC , te Riele HP , Riele HP , Berns AJ , Borst P . 1994 . Disruption of the mouse mdr1a P‐glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs . Cell 77 : 491 – 502 . 

   상세보기

3. 3 Lespine A , Dupuy J , Alvinerie M , Comera C , Nagy T , Krajcsi P , Orlowski S . 2009 . Interaction of macrocyclic lactones with the multidrug transporters: The bases of the pharmacokinetics of lipid‐like drugs . Curr Drug Metab 10 : 272 – 288 . 

4. 4 Gonzalez‐Canga A , Fernandez‐Martinez N , Sahagun‐Prieto A , Diez‐Liebana MJ , Sierra‐Vega M , Garcia‐Vieitez JJ . 2009 . A review of the pharmacological interactions of ivermectin in several animal species . Curr Drug Metab 10 : 359 – 368 . 

5. 5 Zeng Z , Andrew NW , Arison BH , Luffer‐Atlas D , Wang RW . 1998 . Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes . Xenobiotica 28 : 313 – 321 . 

   상세보기

6. 6 Schinkel AH , Wagenaar E , van Deemter L , Mol CA , Borst P . 1995 . Absence of the mdr1a P‐glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A . J Clin Invest 96 : 1698 – 1705 . 

   상세보기

7. 7 Lespine A , Dupuy J , Orlowski S , Nagy T , Glavinas H , Krajcsi P , Alvinerie M . 2006 . Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3) . Chem Biol Interact 159 : 169 – 179 . 

   상세보기

8. 8 Kiki‐Mvouaka S , Menez C , Borin C , Lyazrhi F , Foucaud‐Vignault M , Dupuy J , Collet X , Alvinerie M , Lespine A . 2010 . Role of P‐glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin and moxidectin in mice . Drug Metab Dispos 38 : 573 – 580 . 

   상세보기

9. 9 El‐Tahtawy A , Glue P , Andrews EN , Mardekian J , Amsden GW , Knirsch CA . 2008 . The effect of azithromycin on ivermectin pharmacokinetics—A population pharmacokinetic model analysis . PLoS Negl Trop Dis 2 : e236 . 

10. 10 Sarkadi B , Homolya L , Szakacs G , Varadi A . 2006 . Human multidrug resistance ABCB and ABCG transporters: Participation in a chemoimmunity defense system . Physiol Rev 86 : 1179 – 1236 . 

    상세보기

11. 11 Enokizono J , Kusuhara H , Ose A , Schinkel AH , Sugiyama Y . 2008 . Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds . Drug Metab Dispos 36 : 995 – 1002 . 

    상세보기

12. 12 Zaher H , Khan AA , Palandra J , Brayman TG , Yu L , Ware JA . 2006 . Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse . Mol Pharm 3 : 55 – 61 . 

    상세보기

13. 13 Vlaming ML , Pala Z , van Esch A , Wagenaar E , de Waart DR , van de Wetering K , van der Kruijssen CM , Oude Elferink RP , van Tellingen O , Schinkel AH . 2009 . Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7‐hydroxymethotrexate in vivo . Clin Cancer Res 15 : 3084 – 3093 . 

    상세보기

14. 14 Urquhart BL , Ware JA , Tirona RG , Ho RH , Leake BF , Schwarz UI , Zaher H , Palandra J , Gregor JC , Dresser GK , Kim RB . 2008 . Breast cancer resistance protein (ABCG2) and drug disposition: Intestinal expression, polymorphisms and sulfasalazine as an in vivo probe . Pharmacogenet Genomics 18 : 439 – 448 . 

    상세보기

15. 15 Yamasaki Y , Ieiri I , Kusuhara H , Sasaki T , Kimura M , Tabuchi H , Ando Y , Irie S , Ware J , Nakai Y , Higuchi S , Sugiyama Y . 2008 . Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans . Clin Pharmacol Ther 84 : 95 – 103 . 

    상세보기

16. 16 Merino G , Real R , Baro MF , Gonzalez‐Lobato L , Prieto JG , Alvarez AI , Marques MM . 2009 . Natural allelic variants of bovine ATP‐binding cassette transporter ABCG2: Increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors . Drug Metab Dispos 37 : 5 – 9 . 

    상세보기

17. 17 Muenster U , Grieshop B , Ickenroth K , Gnoth MJ . 2008 . Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug–drug interactions . Pharm Res 25 : 2320 – 2326 . 

    상세보기

18. 18 Geyer J , Gavrilova O , Petzinger E . 2009 . Brain penetration of ivermectin and selamectin in mdr1a,b P‐glycoprotein‐ and bcrp‐deficient knockout mice . J Vet Pharmacol Ther 32 : 87 – 96 . 

    상세보기

19. 19 Kis E , Nagy T , Jani M , Molnar E , Janossy J , Ujhellyi O , Nemet K , Heredi‐Szabo K , Krajcsi P . 2009 . Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: Implications for drug resistance . Ann Rheum Dis 68 : 1201 – 1207 . 

20. 20 von Richter O , Glavinas H , Krajcsi P , Liehner S , Siewert B , Zech K . 2009 . A novel screening strategy to identify ABCB1 substrates and inhibitors . Naunyn Schmiedebergs Arch Pharmakol 379 : 11 – 26 . 

21. 21 Glavinas H , Kis E , Pal A , Kovacs R , Jani M , Vagi E , Molnar E , Bansaghi S , Kele Z , Janaky T , Bathori G , von Richter O , Koomen GJ , Krajcsi P . 2007 . ABCG2 (breast cancer resistance protein/mitoxantrone resistance‐associated protein) ATPase assay: A useful tool to detect drug–transporter interactions . Drug Metab Dispos 35 : 1533 – 1542 . 

    상세보기

22. 22 Lespine A , Martin S , Dupuy J , Roulet A , Pineau T , Orlowski S , Alvinerie M . 2007 . Interaction of macrocyclic lactones with P‐glycoprotein: Structure–affinity relationship . Eur J Pharm Sci 30 : 84 – 94 . 

    상세보기

23. 23 Margolis JM , Obach RS . 2003 . Impact of nonspecific binding to microsomes and phospholipid on the inhibition of cytochrome P4502D6: Implications for relating in vitro inhibition data to in vivo drug interactions . Drug Metab Dispos 31 : 606 – 611 . 

    상세보기

24. 24 Obach RS . 1999 . Prediction of human clearance of twenty‐nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half‐life approach and nonspecific binding to microsomes . Drug Metab Dispos 27 : 1350 – 1359 . 

    상세보기